Skip to main content

COMMUNITY CASE STUDY article

Front. Public Health
Sec. Substance Use Disorders and Behavioral Addictions
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1375323

Evaluating Mobile Harm Reduction Services for Youth and Young Adults

Provisionally accepted
  • 1 Harvard Medical School, Boston, United States
  • 2 University of Kentucky, Lexington, Kentucky, United States
  • 3 Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States
  • 4 Boston Health Care for the Homeless Program, Boston, Massachusetts, United States
  • 5 Department of Medicine, School of Medicine, Boston University, Boston, Massachusetts, United States

The final, formatted version of the article will be published soon.

    The adolescent and young adult (AYA) population has experienced an increase in both emergency room visits and deaths related to substance use. However, AYA are less likely to engage in existing addiction treatment infrastructure. A youth-specific mobile harm reduction program has the potential to reduce substance-related morbidity and mortality including infections, overdose, and death. Launched in 2019, the Community Care in Reach AYA pilot program seeks to address the difference in patterns of substance use between AYA and adults. The results of this evaluation suggest the importance of a youth-oriented program in increasing AYA engagement with harm reduction.

    Keywords: Harm Reduction, Youth, mobile health, substance use disorder, addiction Krug ctiation doi: 10.7448/IAS.18.2.19442

    Received: 23 Jan 2024; Accepted: 06 May 2024.

    Copyright: © 2024 Yeo, Hausman, Noyes and Chatterjee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ellis J. Yeo, Harvard Medical School, Boston, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.